123 related articles for article (PubMed ID: 22964517)
1. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells.
Navarro-Montero O; Romero-Moya D; Montes R; Ramos-Mejía V; Bueno C; Real PJ; Menendez P
Clin Immunol; 2012 Nov; 145(2):89-91. PubMed ID: 22964517
[No Abstract] [Full Text] [Related]
2. Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.
Wong WM; Sigvardsson M; Åstrand-Grundström I; Hogge D; Larsson J; Qian H; Ekblom M
Stem Cells; 2013 Feb; 31(2):360-71. PubMed ID: 23165626
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
[TBL] [Abstract][Full Text] [Related]
4. Human T cell development in the liver of humanized NOD/SCID/IL-2Rγ(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells.
Choi B; Chun E; Kim M; Kim SY; Kim ST; Yoon K; Lee KY; Kim SJ
Clin Immunol; 2011 Jun; 139(3):321-35. PubMed ID: 21429805
[TBL] [Abstract][Full Text] [Related]
5. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
6. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
[TBL] [Abstract][Full Text] [Related]
7. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
[TBL] [Abstract][Full Text] [Related]
8. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
9. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
10. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
12. Clinical-scale expansion of CD34
Casamayor-Genescà A; Pla A; Oliver-Vila I; Pujals-Fonts N; Marín-Gallén S; Caminal M; Pujol-Autonell I; Carrascal J; Vives-Pi M; Garcia J; Vives J
N Biotechnol; 2017 Mar; 35():19-29. PubMed ID: 27810336
[TBL] [Abstract][Full Text] [Related]
13. Cellular-based therapies to prevent or reduce thrombocytopenia.
Pineault N; Boyer L
Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.
Robinson SN; Simmons PJ; Thomas MW; Brouard N; Javni JA; Trilok S; Shim JS; Yang H; Steiner D; Decker WK; Xing D; Shultz LD; Savoldo B; Dotti G; Bollard CM; Miller L; Champlin RE; Shpall EJ; Zweidler-McKay PA
Exp Hematol; 2012 Jun; 40(6):445-56. PubMed ID: 22306295
[TBL] [Abstract][Full Text] [Related]
15. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
[TBL] [Abstract][Full Text] [Related]
16. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.
Yahata T; Ando K; Miyatake H; Uno T; Sato T; Ito M; Kato S; Hotta T
Mol Ther; 2004 Nov; 10(5):882-91. PubMed ID: 15509506
[TBL] [Abstract][Full Text] [Related]
17. Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/gamma(c)null mice through cell fusion.
Fujino H; Hiramatsu H; Tsuchiya A; Niwa A; Noma H; Shiota M; Umeda K; Yoshimoto M; Ito M; Heike T; Nakahata T
FASEB J; 2007 Nov; 21(13):3499-510. PubMed ID: 17576850
[TBL] [Abstract][Full Text] [Related]
18. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
[TBL] [Abstract][Full Text] [Related]
19. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
[TBL] [Abstract][Full Text] [Related]
20. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
